Literature DB >> 25586245

Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome.

Yumiko Sasaki1, Yasuo Kohjimoto, Akinori Iba, Nagahide Matsumura, Isao Hara.   

Abstract

OBJECTIVES: To investigate the effect of weight loss intervention on the urinary stone risk parameters in a rat model of metabolic syndrome.
METHODS: In a prevention study, 4-week-old male Otsuka Long-Evans Tokushima "Fatty" rats were randomly assigned to three groups: control, food-restricted and food-restricted + exercise-trained groups. In a treatment study, 24-week-old male Otsuka Long-Evans Tokushima "Fatty" rats that had already developed type 2 diabetes were randomly assigned to the same three groups. Blood and 24-h urine chemistry were measured after 16 weeks.
RESULTS: In both studies, food-restricted and food-restricted + exercise-trained rats showed significantly higher urinary pH and higher excretion of urinary citrate than control rats. In the prevention study, ion-activity products of calcium oxalate in the food-restricted and food-restricted + exercise-trained groups were significantly lower than that of control rats. In the treatment study, ion-activity products of calcium oxalate index in food-restricted + exercise-trained rats was significantly lower than that of control rats.
CONCLUSIONS: Weight loss intervention seems to reduce the risk of uric acid stone formation by improving low urine pH and calcium oxalate stone formation by increasing urinary citrate excretion. The present study provides the first theoretical evidence to support weight loss intervention programs for nephrolithiasis patients with metabolic syndrome.
© 2015 The Japanese Urological Association.

Entities:  

Keywords:  animal models; kidney stone; metabolic syndrome; rat; weight loss

Mesh:

Substances:

Year:  2015        PMID: 25586245     DOI: 10.1111/iju.12691

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  6 in total

Review 1.  Metabolic Syndrome-Related Kidney Injury: A Review and Update.

Authors:  Lirong Lin; Wei Tan; Xianfeng Pan; En Tian; Zhifeng Wu; Jurong Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

2.  Metabolic Syndrome and Nephrolithiasis Risk: Should the Medical Management of Nephrolithiasis Include the Treatment of Metabolic Syndrome?

Authors:  John Michael DiBianco; T W Jarrett; Patrick Mufarrij
Journal:  Rev Urol       Date:  2015

Review 3.  Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies.

Authors:  Dagfinn Aune; Yahya Mahamat-Saleh; Teresa Norat; Elio Riboli
Journal:  Eur J Epidemiol       Date:  2018-07-31       Impact factor: 8.082

4.  Inhibitive Effects of Huashi Pill on Formation of Renal Stones by Modulating Urine Biochemical Indexes and Osteopontin in Renal Stone Rat Models.

Authors:  Ailing Yang; Huimeng Guo; Manling Fu; Minyong Liu
Journal:  Med Sci Monit       Date:  2019-11-06

5.  Incidence and correlation of metabolic syndrome and kidney stones in a healthy screening population.

Authors:  Feng Qiu; Yunfeng Xu; Xiaodong Ji; Jinxian Pu; Jian Zhou; Yuhua Huang
Journal:  Transl Androl Urol       Date:  2021-09

Review 6.  The influence of metabolic syndrome and its components on the development of nephrolithiasis.

Authors:  Carter Boyd; Kyle Wood; Dustin Whitaker; Dean G Assimos
Journal:  Asian J Urol       Date:  2018-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.